Insulrap Spp

Insulrap SPP: description, application and features

Insulin is one of the main medications for the treatment of diabetes, which is used to maintain proper blood glucose levels. One of the representatives of short-acting insulins is Insulrap SPP.

Insulrap SPP is produced by the Croatian company Pliva and belongs to the group of short-acting insulins. It is an injection solution with a concentration of 40 units/ml and has the international name Insulin-BD.

Synonyms for Insulrap SPP include drugs such as Berlinsulin N Normal U-40, Berlinsulin N Normal pen, Biogulin Regular U-100, Biogulin Regular U-40, Biosulin N, Brinsulrapi MK, Brinsulrapi H, Insulin, Insulin "M", Insulin Actrapid, Insulin Actrapid MK, Insulin Actrapid MS, Insulin Iletin II Regular and others.

Insulin-BD, to which Insulrap SPP belongs, differs from other short-acting insulins in that it contains less zinc. This results in a faster onset of insulin action and a shorter period of action compared to other short-acting insulins.

Insulrap SPP is used to treat diabetes mellitus in adults and children. It can be used as a single injection to correct blood glucose levels, or in combination with other insulins to maintain stable blood glucose levels throughout the day.

When using Insulrap SPP, it is necessary to follow an individual dosage regimen and regularly monitor blood glucose levels to avoid the development of hypoglycemia or hyperglycemia. Insulin should be stored in the refrigerator at a temperature of 2 to 8 degrees Celsius.

In conclusion, Insulrap SPP is one of the short-acting insulins that is used to treat diabetes mellitus. It is characterized by a faster onset of action and a shorter period of action compared to other short-acting insulins. However, like any other drug, it must be used only as prescribed by a doctor and in compliance with an individual dosing regimen and monitoring blood glucose levels.